Try our Advanced Search for more refined results

AstraZeneca's $1B Drug Protections Too Vague, Generics Say

By Alex Baldwin ( March 10, 2025, 5:40 PM GMT) -- Generic drugmakers urged the High Court to revoke patent protections for AstraZeneca's $1 billion Type-2 diabetes treatment Forxiga at the start of invalidity proceedings on Monday as the pharmaceutical companies hope to clear the way to launch their competitor medicines....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!